(S (NP (JJ Current) (NML (NN pharmaceutical) (NN formulation)) (NN development)) (ADVP (RB still)) (ADVP (RB strongly)) (VP (VBZ relies) (PP (IN on) (NP (DT the) (JJ traditional) (NML (NN trial) (HYPH -) (CC and) (HYPH -) (NN error)) (NN approach))) (PP (IN by) (NP (NP (NP (JJ individual) (NNS experiences)) (PP (IN of) (NP (JJ pharmaceutical) (NNS scientists)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (ADJP (JJ laborious)) (, ,) (ADJP (NN time) (HYPH -) (VBG consuming)) (CC and) (ADJP (JJ costly))))))))) (. .))
(S (ADVP (RB Recently)) (, ,) (NP (JJ deep) (NN learning)) (VP (VBZ has) (VP (VBN been) (ADVP (RB widely)) (VP (VBN applied) (PP (IN in) (NP (JJ many) (JJ challenging) (NNS domains))) (PP (IN because) (PP (IN of) (NP (NP (PRP$ its) (JJ important) (NN capability)) (PP (IN of) (NP (JJ automatic) (NN feature) (NN extraction))))))))) (. .))
(S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN research)))) (VP (VBZ is) (S (VP (TO to) (VP (VB use) (NP (JJ deep) (NN learning)) (S (VP (TO to) (VP (VB predict) (NP (JJ pharmaceutical) (NNS formulations))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (NP (CD two) (JJ different) (NNS types)) (PP (IN of) (NP (NN dosage) (NNS forms)))) (VP (VBD were) (VP (VBN chosen) (PP (IN as) (NP (NN model) (NNS systems))))) (. .))
(S (NP (NP (NN Evaluation) (NNS criteria)) (ADJP (JJ suitable) (PP (IN for) (NP (NNS pharmaceutics))))) (VP (VBD were) (VP (VBN applied) (PP (IN to) (S (VP (VBG assessing) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (DT the) (NNS models))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP (DT an) (JJ automatic) (NN dataset) (NN selection) (NN algorithm)) (VP (VBD was) (VP (VBN developed) (PP (IN for) (S (VP (VBG selecting) (NP (DT the) (NN representative) (NNS data)) (PP (IN as) (NP (NN validation) (CC and) (NN test) (NNS datasets)))))))) (. .))
(S (NP (CD Six) (NML (NN machine) (NN learning)) (NNS methods)) (VP (VBD were) (VP (VBN compared) (PP (IN with) (NP (JJ deep) (NN learning))))) (. .))
(S (NP (DT The) (NN result)) (VP (VBZ shows) (SBAR (S (NP (NP (DT the) (NNS accuracies)) (PP (IN of) (NP (DT both) (CD two) (JJ deep) (JJ neural) (NNS networks)))) (VP (VBD were) (PP (IN above) (NP (NP (CD 80) (NN %)) (CC and) (NP (JJR higher)))) (PP (IN than) (NP (NP (JJ other) (NML (NN machine) (NN learning)) (NNS models)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD showed) (NP (JJ good) (NN prediction)) (PP (IN in) (NP (JJ pharmaceutical) (NNS formulations)))))))))))) (. .))
(S (PP (IN In) (NP (NN summary))) (, ,) (NP (NP (JJ deep) (NN learning)) (PP (IN with) (NP (NP (DT the) (NML (S (NP (JJ automatic) (NNS data)) (VP (JJ splitting)))) (NN algorithm)) (CC and) (NP (NP (DT the) (NN evaluation) (NNS criteria)) (ADJP (JJ suitable) (PP (IN for) (NP (JJ pharmaceutical) (NN formulation) (NNS data)))))))) (VP (VBD was) (ADVP (RB firstly)) (VP (VBN developed) (PP (IN for) (NP (NP (DT the) (NN prediction)) (PP (IN of) (NP (JJ pharmaceutical) (NNS formulations))))))) (. .))
(S (NP (NP (DT The) (JJ cross-disciplinary) (NN integration)) (PP (IN of) (NP (NP (NNS pharmaceutics)) (CC and) (NP (JJ artificial) (NN intelligence))))) (VP (MD may) (VP (VB shift) (NP (NP (DT the) (NN paradigm)) (PP (IN of) (NP (NP (JJ pharmaceutical) (NNS researches)) (PP (IN from) (NP (ADJP (NN experience) (HYPH -) (JJ dependent)) (NNS studies)))))) (PP (IN to) (NP (ADJP (NN data) (HYPH -) (VBN driven)) (NNS methodologies))))) (. .))
